Actively Recruiting
Study Comparing Ella Photodynamic Therapy and LEEP Surgery for Treating Cervical HSILCIN2
Led by Second Affiliated Hospital, Zhejiang University, School of Medicine · Updated on 2026-10-14
560
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of 5-aminolevulinic acid photodynamic therapy ALA-PDT compared with loop electrosurgical excision procedure LEEP for treating cervical high-grade squamous intraepithelial lesion HSILCIN2. The study aims to show that ALA-PDT is not less effective than LEEP in clinical outcomes. It also assesses safety, cervical tissue healing, and long-term results to provide evidence supporting ALA-PDT as a less invasive, function-preserving alternative. Participants receive either ALA-PDT, where a 20% ALA gel is applied for 3 hours followed by red light exposure, repeated every 7 to 14 days for 6 to 9 sessions, or LEEP surgery involving cervical iodine staining and excision under anesthesia. These two treatment groups are studied concurrently without randomization to compare their clinical effects. During the study, participants undergo evaluations including lesion effectiveness assessments at 6 months and follow-ups up to 2 years to measure lesion cure and HPV clearance rates. Safety and cervical regeneration are monitored throughout. The trial spans from screening through treatment and long-term follow-up, with the primary outcome measured at 6 months and extended observations to 2 years.
CONDITIONS
Brief Title
Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2
Research Team
X
Xiaoyun Wang, Doctor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here